The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Financial toxicity in cancer care: origins, impact, and solutions
Abstract
Financial toxicity describes the financial burden and distress that can arise for patients, and their family members, as a result of cancer treatment. It includes direct out-of-pocket costs for treatment and indirect costs such as travel, time, and changes to employment that can increase the burden of cancer. While high costs of cancer care have threatened the sustainability of access to care for decades, it is only in the past 10 years that the term “financial toxicity” has been popularized to recognize that the financial burdens of care can be just as important as the physical toxicities traditionally associated with cancer therapy. The past decade has seen a rapid growth in research identifying the prevalence and impact of financial toxicity. Research is now beginning to focus on innovations in screening and care delivery that can mitigate this risk. There is a need to determine the optimal strategy for clinicians and cancer centers to address costs of care in order to minimize financial toxicity, promote access to high value care, and reduce health disparities. We review the evolution of concerns over costs of cancer care, the impact of financial burdens on patients, methods to screen for financial toxicity, proposed solutions, and priorities for future research to identify and address costs that threaten the health and quality of life for many patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cherny, N. I., Sullivan, R., Dafni, U., Kerst, J. M., Sobrero, A., Zielinski, C., de Vries, E. G. E., & Piccart, M. J. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv249 · Cited by 818
Delivering affordable cancer care in high-income countries
Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I. F., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70141-3 · Cited by 718
Self-citationStarr, L. T., Ulrich, C. M., Corey, K. L., & Meghani, S. H. (2019) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909119848148 · Cited by 132 · cited 1×
“survivorship needs [28]; and palliative or end-of-life care, conveying particularly high costs in the last days or weeks of a patient’s life [29].”
The direct and indirect financial costs of informal cancer care: A scoping review
Coumoundouros, C., Ould Brahim, L., Lambert, S. D., & McCusker, J. (2019) · Health & Social Care in the Community · doi:10.1111/hsc.12808 · Cited by 92 · cited 1×
“Further, there is a need to evaluate the broader impact of costs of cancer care on the burden, health, and health care decisions of caregivers [129].”
Hutchcraft, M. L., Teferra, A. A., Montemorano, L., & Patterson, J. G. (2021) · LGBT Health · doi:10.1089/lgbt.2020.0185 · Cited by 47
Cited by
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach
Smith, G. L., Banegas, M. P., Acquati, C., Chang, S., Chino, F., Conti, R. M., Greenup, R. A., Kroll, J. L., Liang, M. I., Pisu, M., et al. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21730 · Cited by 260
Ma, G., Long, N., Mao, P., Li, Y., Li, F., & Li, C. (2025) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2025.100761 · Cited by 8
Metadata
- Authors
- Abrams, H. R., Durbin, S., Huang, C. X., Johnson, S. F., Nayak, R. K., Zahner, G. J., & Peppercorn, J.
- Venue
- Translational Behavioral Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-11-01
- Volume
- 11
- Issue
- 11
- Pages
- 2043-2054
- ISSN
- 1613-9860 (ISSN-L)
- 1869-6716
- OpenAlex
- W3216829190
- Cited by
- 250
- References
- 5
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Financial toxicity in cancer care: origins, impact, and solutions. https://app.cochat.ai/papers/10.1093/tbm/ibab091
- The paper
- Abrams, H. R., Durbin, S., Huang, C. X., Johnson, S. F., Nayak, R. K., Zahner, G. J., & Peppercorn, J. (2021). Financial toxicity in cancer care: origins, impact, and solutions. Translational Behavioral Medicine. https://doi.org/10.1093/tbm/ibab091
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.